CDKN2B-AS1 and lung cancer: Thus far, ANRIL upregulation is considered the primary feature of many carcinomas, including BC.[24] Lin et al[25] found that ANRIL expression was higher in nonsmall cell lung cancer tissues than adjacent nontumor tissues and was associated with high TNM stage and advanced lymph node metastasis.